ABX-EGF

panitumumab · Amgen

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ABX-EGF, covering 2007-12-24 to 2013-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma [Phase 2]